SBFM
Sunshine Biopharma, Inc.
Price Chart
Latest Quote
$2.13
+0.01 (+0.47%)
Current Price
| Previous Close | $2.12 |
| Open | $2.08 |
| Day High | $2.15 |
| Day Low | $2.06 |
| Volume | 56,612 |
Stock Information
| Shares Outstanding | 2.12M |
| Total Debt | $745K |
| Cash Equivalents | $6.91M |
| Revenue | $35.49M |
| Net Income | $-6.04M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $4.52M |
| EPS (TTM) | $-12.44 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-5.09M |
| Sales | $35.49M |
| Income | $-6.04M |
| Book/sh | $43.83 |
| Cash/sh | $3.26 |
| Employees | 50 |
Financial Ratios
| Quick Ratio | 1.86 |
| Current Ratio | 4.22 |
| Debt/Eq | 3.46 |
Returns & Margins
| ROA | -10.02% |
| ROE | -27.32% |
| Gross Margin | 32.98% |
| Operating Margin | -17.25% |
| Profit Margin | -17.02% |
Ownership
| Insider Ownership | 0.48% |
| Institutional Ownership | 12.87% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 0.01 |
| P/S | 0.13 |
| P/B | 0.05 |
Analyst Data
| Recommendation | none |
| Target Price | $56.00 |
Technical Indicators
| SMA20 | $2.84 |
| SMA50 | $6.57 |
| SMA200 | $12.03 |
| RSI | 36.77 |
| ATR | 0.2745 |
| Shares Float | 497K |
| Short Float | 6.83% |
| Short Ratio | 0.04 |
| Rel Volume | 0.02 |
Performance History
| Week | -10.13% |
| Month | -51.59% |
| Quarter | -80.46% |
| 6 Months | -84.57% |
| YTD | -83.36% |
| Year | -85.51% |
| 3 Years | -99.98% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.13 | 58,800 |
| 2026-06-17 | $2.12 | 71,500 |
| 2026-06-16 | $2.14 | 85,400 |
| 2026-06-15 | $2.28 | 114,900 |
| 2026-06-12 | $2.22 | 119,200 |
| 2026-06-11 | $2.37 | 380,600 |
| 2026-06-10 | $2.14 | 192,000 |
| 2026-06-09 | $2.28 | 271,000 |
| 2026-06-08 | $2.43 | 203,000 |
| 2026-06-05 | $2.46 | 283,000 |
| 2026-06-04 | $2.57 | 475,300 |
| 2026-06-03 | $2.66 | 861,100 |
| 2026-06-02 | $2.60 | 13,312,200 |
| 2026-06-01 | $2.39 | 468,400 |
| 2026-05-29 | $2.54 | 673,530 |
| 2026-05-28 | $3.17 | 1,059,830 |
| 2026-05-27 | $4.24 | 530,580 |
| 2026-05-26 | $4.17 | 818,440 |
| 2026-05-22 | $4.81 | 1,661,570 |
| 2026-05-21 | $5.16 | 28,614,660 |
| 2026-05-20 | $3.67 | 1,002,450 |
| 2026-05-19 | $4.40 | 4,016,840 |
About Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $24,050,214 | $24,204,489 | $15,753,616 | $2,649,028 |
| Cost Of Revenue | $24,050,214 | $24,204,489 | $15,753,616 | $2,649,028 |
| Total Revenue | $36,305,891 | $34,874,283 | $24,092,787 | $4,345,603 |
| Operating Revenue | $36,305,891 | $34,874,283 | $24,092,787 | $4,345,603 |
| Expenses | ||||
| Interest Expense | $0 | $8,774 | $137,308 | $39,412 |
| Total Expenses | $40,784,673 | $40,686,404 | $28,878,086 | $13,019,634 |
| Other Income Expense | $-1,755,862 | $-44,082 | $-245 | $-18,316,343 |
| Net Non Operating Interest Income Expense | $280,901 | $487,229 | $674,666 | $479,238 |
| Interest Expense Non Operating | $0 | $8,774 | $137,308 | $39,412 |
| Operating Expense | $16,734,459 | $16,481,915 | $13,124,470 | $10,370,606 |
| Selling And Marketing Expense | $1,143,929 | $940,278 | $734,248 | $578,085 |
| General And Administrative Expense | $14,184,847 | $13,997,203 | $10,095,508 | $8,900,267 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Net Interest Income | $280,901 | $487,229 | $674,666 | $479,238 |
| Interest Income | $280,901 | $496,003 | $811,974 | $518,650 |
| Normalized Income | $-4,588,221 | $-5,091,960 | $-4,505,850 | $-12,274,529 |
| Net Income From Continuing And Discontinued Operation | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Total Operating Income As Reported | $-6,227,029 | $-5,812,121 | $-4,785,299 | $-27,000,750 |
| Net Income Common Stockholders | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Net Income | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Net Income Including Noncontrolling Interests | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Net Income Continuous Operations | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Pretax Income | $-5,953,743 | $-5,368,974 | $-4,110,878 | $-26,511,136 |
| Special Income Charges | $-1,758,504 | $0 | $0 | $-18,315,867 |
| Interest Income Non Operating | $280,901 | $496,003 | $811,974 | $518,650 |
| Operating Income | $-4,478,782 | $-5,812,121 | $-4,785,299 | $-8,674,031 |
| Depreciation Amortization Depletion Income Statement | $332,070 | $223,527 | $149,147 | $25,163 |
| Depreciation And Amortization In Income Statement | $332,070 | $223,527 | $149,147 | $25,163 |
| Gross Profit | $12,255,677 | $10,669,794 | $8,339,171 | $1,696,575 |
| Depreciation Income Statement | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-14.40 | $-73.20 | $-3513.60 | $-23688.61 |
| Basic EPS | $-14.40 | $-73.20 | $-3513.60 | $-23688.61 |
| Other | ||||
| Tax Effect Of Unusual Items | $-368,731 | $-1,926 | $-51 | $-3,846,432 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,865,811 | $-5,092,591 | $-3,824,178 | $-8,130,218 |
| Total Unusual Items | $-1,755,862 | $-44,082 | $-245 | $-18,316,343 |
| Total Unusual Items Excluding Goodwill | $-1,755,862 | $-44,082 | $-245 | $-18,316,343 |
| Reconciled Depreciation | $332,070 | $223,527 | $149,147 | $25,163 |
| EBITDA (Bullshit earnings) | $-5,621,673 | $-5,136,673 | $-3,824,423 | $-26,446,561 |
| EBIT | $-5,953,743 | $-5,360,200 | $-3,973,570 | $-26,471,724 |
| Diluted Average Shares | $415,708 | $70,174 | $1,282 | $1,129 |
| Basic Average Shares | $415,708 | $70,174 | $1,282 | $1,129 |
| Diluted NI Availto Com Stockholders | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Tax Provision | $21,609 | $-234,858 | $395,166 | $233,304 |
| Gain On Sale Of Ppe | $-10,257 | $0 | - | - |
| Impairment Of Capital Assets | $1,748,247 | $0 | $0 | $18,326,719 |
| Gain On Sale Of Security | $2,642 | $-44,082 | $-245 | $-476 |
| Other Taxes | $469,305 | $387,005 | $289,737 | $55,233 |
| Research And Development | $604,308 | $933,902 | $1,855,830 | $811,858 |
| Selling General And Administration | $15,328,776 | $14,937,481 | $10,829,756 | $9,478,352 |
| Other Gand A | $6,519,501 | $5,878,526 | $3,982,540 | $2,545,305 |
| Salaries And Wages | $7,665,346 | $8,118,677 | $6,112,968 | $6,354,962 |
| Other Special Charges | - | - | - | $-10,852 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $21,149,090 | $20,481,037 | $19,763,102 | $20,850,714 |
| Total Assets | $30,079,167 | $30,560,392 | $27,346,961 | $29,243,848 |
| Total Non Current Assets | $3,205,586 | $4,594,043 | $2,456,906 | $1,931,514 |
| Non Current Deferred Assets | $0 | $92,234 | $0 | - |
| Non Current Deferred Taxes Assets | $0 | $92,234 | $0 | - |
| Goodwill And Other Intangible Assets | $1,889,370 | $3,019,717 | $1,444,259 | $776,856 |
| Current Assets | $26,853,581 | $25,966,349 | $24,890,055 | $27,312,334 |
| Prepaid Assets | $798,384 | $1,133,297 | $310,591 | $283,799 |
| Inventory | $13,472,025 | $11,278,105 | $5,734,755 | $3,289,945 |
| Receivables | $3,459,864 | $3,868,418 | $2,552,362 | $1,912,153 |
| Accounts Receivable | $3,459,864 | $3,868,418 | $2,552,362 | $1,912,153 |
| Cash Cash Equivalents And Short Term Investments | $9,123,308 | $9,686,529 | $16,292,347 | $21,826,437 |
| Cash And Cash Equivalents | $9,123,308 | $9,686,529 | $16,292,347 | $21,826,437 |
| Cash Financial | $9,123,308 | $9,686,529 | $16,292,347 | $21,826,437 |
| Debt | ||||
| Total Debt | $812,422 | $952,480 | $657,705 | $765,258 |
| Long Term Debt And Capital Lease Obligation | $596,785 | $744,724 | $539,035 | $642,232 |
| Current Debt And Capital Lease Obligation | $215,637 | $207,756 | $118,670 | $123,026 |
| Current Debt | - | - | - | $3,632,000 |
| Other Current Borrowings | - | - | - | $3,632,000 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,040,707 | $7,059,638 | $6,139,600 | $7,616,278 |
| Total Non Current Liabilities Net Minority Interest | $596,785 | $744,724 | $587,764 | $685,264 |
| Current Liabilities | $6,443,922 | $6,314,914 | $5,551,836 | $6,931,014 |
| Payables And Accrued Expenses | $6,228,285 | $6,107,158 | $5,433,166 | $6,807,988 |
| Payables | $6,228,285 | $6,107,158 | $5,433,166 | $6,807,988 |
| Other Payable | $295,797 | $295,797 | $2,547,831 | $3,632,000 |
| Total Tax Payable | $268,276 | $268,276 | $299,869 | $373,191 |
| Income Tax Payable | $268,276 | $268,276 | $299,869 | $373,191 |
| Accounts Payable | $5,664,212 | $5,543,085 | $2,585,466 | $2,802,797 |
| Non Current Deferred Liabilities | - | $0 | $48,729 | $43,032 |
| Non Current Deferred Taxes Liabilities | - | $0 | $48,729 | $43,032 |
| Other Current Liabilities | - | - | - | $123,027 |
| Interest Payable | - | - | - | $0 |
| Current Notes Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $23,025,460 | $23,487,754 | $21,206,361 | $21,626,570 |
| Preferred Stock Equity | $13,000 | $13,000 | $1,000 | $1,000 |
| Total Equity Gross Minority Interest | $23,038,460 | $23,500,754 | $21,207,361 | $21,627,570 |
| Stockholders Equity | $23,038,460 | $23,500,754 | $21,207,361 | $21,627,570 |
| Gains Losses Not Affecting Retained Earnings | $-65,309 | $-829,959 | $696,105 | $161,847 |
| Other Equity Adjustments | $-65,309 | $-829,959 | $696,105 | $161,847 |
| Retained Earnings | $-75,015,126 | $-69,039,774 | $-63,905,658 | $-59,399,614 |
| Other | ||||
| Ordinary Shares Number | $490,594 | $258,009 | $1,401 | $1,129 |
| Share Issued | $490,594 | $258,009 | $1,401 | $1,129 |
| Tangible Book Value | $21,136,090 | $20,468,037 | $19,762,102 | $20,849,714 |
| Invested Capital | $23,025,460 | $23,487,754 | $21,206,361 | $21,626,570 |
| Working Capital | $20,409,659 | $19,651,435 | $19,338,219 | $20,381,320 |
| Capital Lease Obligations | $812,422 | $952,480 | $657,705 | $765,258 |
| Total Capitalization | $23,038,460 | $23,500,754 | $21,207,361 | $21,627,570 |
| Additional Paid In Capital | $98,100,990 | $93,354,907 | $84,415,900 | $80,841,752 |
| Capital Stock | $17,905 | $15,580 | $1,014 | $23,585 |
| Common Stock | $4,905 | $2,580 | $14 | $22,585 |
| Preferred Stock | $13,000 | $13,000 | $1,000 | $1,000 |
| Long Term Capital Lease Obligation | $596,785 | $744,724 | $539,035 | $642,232 |
| Current Capital Lease Obligation | $215,637 | $207,756 | $118,670 | $123,026 |
| Net PPE | $1,316,216 | $1,482,092 | $1,012,647 | $1,154,658 |
| Accumulated Depreciation | $-512,879 | $-336,533 | $-189,996 | $-83,806 |
| Gross PPE | $1,829,095 | $1,818,625 | $1,202,643 | $1,238,464 |
| Leases | $92,706 | $88,306 | $17,664 | $0 |
| Other Properties | $335,464 | $336,880 | $171,859 | $922,943 |
| Machinery Furniture Equipment | $622,079 | $457,402 | $366,341 | $315,521 |
| Buildings And Improvements | $778,846 | $936,037 | $646,779 | - |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $13,472,025 | $11,278,105 | $5,734,755 | - |
| Current Accrued Expenses | - | - | - | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-6,167,379 | $-14,504,092 | $-9,563,210 | $-5,553,355 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,331,073 | $-12,524,779 | $-8,775,111 | $-5,248,358 |
| Cash Flow From Continuing Operating Activities | $-5,331,073 | $-12,524,779 | $-8,775,111 | $-5,248,358 |
| Operating Gains Losses | $10,257 | - | - | $548 |
| Investing Activities | ||||
| Capital Expenditure | $-836,306 | $-1,979,313 | $-788,099 | $-304,997 |
| Investing Cash Flow | $-836,306 | $-1,979,313 | $-656,150 | $-14,619,390 |
| Cash Flow From Continuing Investing Activities | $-836,306 | $-1,979,313 | $-656,150 | $-14,619,390 |
| Cash From Discontinued Investing Activities | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-3,139,651 | $-541,143 | $-99,000 |
| Issuance Of Capital Stock | $1,828,596 | $8,522,411 | $4,089,218 | $30,367,185 |
| Financing Cash Flow | $4,748,408 | $8,941,572 | $3,425,587 | $39,465,107 |
| Cash Flow From Continuing Financing Activities | $4,748,408 | $8,941,572 | $3,425,587 | $39,465,107 |
| Net Common Stock Issuance | $1,828,596 | $5,382,760 | $3,548,075 | $30,268,185 |
| Common Stock Issuance | $1,828,596 | $8,522,411 | $4,089,218 | $30,367,185 |
| Net Other Financing Charges | - | - | - | $-2,064,331 |
| Net Preferred Stock Issuance | - | - | - | $-99,000 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $8,126 | $0 | $48,287 |
| Income Tax Paid Supplemental Data | $0 | $582,483 | $0 | $0 |
| End Cash Position | $9,123,308 | $9,686,529 | $16,292,347 | $21,826,437 |
| Beginning Cash Position | $9,686,529 | $16,292,347 | $21,826,437 | $2,045,167 |
| Effect Of Exchange Rate Changes | $855,750 | $-1,043,298 | $471,584 | $183,911 |
| Changes In Cash | $-1,418,971 | $-5,562,520 | $-6,005,674 | $19,597,359 |
| Proceeds From Stock Option Exercised | $2,919,812 | $3,558,812 | $3,502 | $13,193,177 |
| Common Stock Payments | $0 | $-3,139,651 | $-541,143 | $-99,000 |
| Net Intangibles Purchase And Sale | $-661,815 | $-322,258 | $-705,848 | $-111,015 |
| Purchase Of Intangibles | $-661,815 | $-322,258 | $-705,848 | $-111,015 |
| Net PPE Purchase And Sale | $-174,491 | $-1,657,055 | $49,698 | $-160,603 |
| Purchase Of PPE | $-174,491 | $-1,657,055 | $-82,251 | $-193,982 |
| Change In Working Capital | $-1,446,295 | $-5,374,156 | $-4,418,214 | $3,154,504 |
| Change In Other Current Liabilities | $-187,523 | $347,935 | - | - |
| Change In Other Current Assets | $203,836 | $-341,534 | - | - |
| Change In Payables And Accrued Expense | $-189,956 | $3,171,669 | $-1,437,381 | $3,553,161 |
| Change In Payable | $-189,956 | $3,171,669 | $-1,437,381 | $3,601,448 |
| Change In Account Payable | $-189,956 | $3,983,749 | $-1,364,134 | $3,359,141 |
| Change In Tax Payable | $0 | $-812,080 | $-73,247 | $242,307 |
| Change In Income Tax Payable | $0 | $-812,080 | $-73,247 | $242,307 |
| Change In Prepaid Assets | $480,798 | $-207,167 | $-21,143 | $82,846 |
| Change In Inventory | $-1,637,277 | $-6,006,864 | $-2,365,549 | $42,983 |
| Change In Receivables | $-116,173 | $-2,338,195 | $-594,141 | $-524,486 |
| Changes In Account Receivables | $-116,173 | $-2,338,195 | $-594,141 | $-524,486 |
| Asset Impairment Charge | $1,748,247 | $0 | $0 | $18,326,719 |
| Depreciation Amortization Depletion | $332,070 | $223,527 | $149,147 | $25,163 |
| Depreciation And Amortization | $332,070 | $223,527 | $149,147 | $25,163 |
| Gain Loss On Sale Of PPE | $10,257 | $0 | - | - |
| Net Income From Continuing Operations | $-5,975,352 | $-5,134,116 | $-4,506,044 | $-26,744,440 |
| Net Issuance Payments Of Debt | - | $347,935 | $-125,990 | $-1,931,924 |
| Net Long Term Debt Issuance | - | $347,935 | $-125,990 | $-1,931,924 |
| Other Non Cash Items | - | $-2,240,034 | - | $-10,852 |
| Deferred Tax | - | $0 | $0 | - |
| Deferred Income Tax | - | $0 | $0 | - |
| Amortization Cash Flow | - | $77,009 | $38,446 | - |
| Amortization Of Intangibles | - | $77,009 | $38,446 | - |
| Depreciation | - | $146,518 | $110,701 | - |
| Repayment Of Debt | - | - | $0 | $-1,900,000 |
| Long Term Debt Payments | - | - | $0 | $-1,900,000 |
| Net Business Purchase And Sale | - | - | $0 | $-14,347,772 |
| Purchase Of Business | - | - | $0 | $-14,347,772 |
| Sale Of PPE | - | - | $131,949 | $33,379 |
| Change In Accrued Expense | - | - | $0 | $-48,287 |
| Change In Interest Payable | - | - | $0 | $-48,287 |
| Net Foreign Currency Exchange Gain Loss | - | - | $0 | $548 |
| Issuance Of Debt | - | - | - | $0 |
| Preferred Stock Payments | - | - | - | $-99,000 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-17